GlobalData
GlobalData

Irene Robinson

  • Home
  • Author: Irene Robinson

Healthcare sector witnessed 12% decline in deal activity during week ended June 28

The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 12% during the week ended June 28, 2020 compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Though the healthcare sector has been relatively resilient compared to other sectors amid […]
Read more

Adenovirus-vectored vaccines for COVID-19 could face booster issues

The usefulness of adenovirus-vectored vaccines for COVID-19 is currently questionable as these should only be administered two times over the lifetime of an individual and those currently in development only last for a year, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: “Repeated administration of adenovirus-vectored vaccines can […]
Read more

IVIg is available for treating COVID-19

While researchers investigate recovered patient antibody treatments for COVID-19, intravenous immunoglobulin (IVIg) is a similar type of treatment that is already available and could be used for COVID-19, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: “IVIg is generated from the pooled immunoglobulin G of approximately one thousand blood […]
Read more

Less than 30% of AML cases considered to be in adverse risk group

Acute myeloid leukemia (AML), a serious haematological cancer, remains a disease often defined by poor prognosis. However, less than 30% of diagnosed incident cases of AML are considered of adverse risk, according to GlobalData, a leading data analytics company. The company’s latest report, ‘Acute Myeloid Leukemia: Epidemiology Forecast to 2029’, reveals that by 2029, there […]
Read more

Bridge to heart transplant falls short for patients on ECMO highlighting areas of improvement

Following recent guidance from healthcare regulating agencies to increase available extracorporeal membrane oxygenation (ECMO) devices in hospitals for use as an alternative to ventilators, the newest publishing in JACC showing that ventricular assist devices (VAD) devices outperform ECMO units in bridge to heart transplants reminds manufacturers and doctors about the risk factors associated with ECMO, […]
Read more

40% of UK consumers plan to visit shopping centres less often post-COVID-19

Seen as prime destinations before COVID-19 hit, flagship shopping centres will take a long time to attract the same number of consumers back with many shunning the locations to avoid potentially crowded areas and unnecessary travel, says GlobalData, a leading data and analytics company. Sofie Willmott, Lead Analyst at GlobalData, comments: “Supermalls and flagship shopping […]
Read more

Royal Philips obstetrics monitoring product part of shifting landscape to remote monitoring technologies

Following the recent news that Royal Philips has launched its Avalon CL Fetal and Maternal Pod and Patch obstetrics monitoring solution for high-risk expectant mothers; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “The lockdown measures in place across the globe have created the perfect scenario for […]
Read more

Taltz’s Nr-axSpA approval not enough to beat Cosentyx in axSpA

Despite receiving Food and Drug Administration (FDA) approval for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA) before Novartis’s Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) will not overthrow Cosentyx as the premiere anti-interleukin (IL) 17 biologic in the axSpA space. Taltz is forecast to achieve 2028 sales of $239m across the seven major markets (7MM*), whereas […]
Read more

Mortgage market to see short-term hit as consumer spending plummets

Severe economic disruption caused by COVID-19 will see a short-term hit for the UK mortgage market, but payments holidays should keep it afloat and see growth from 2021, says GlobalData, a leading data and analytics company. GlobalData retail banking analyst, Resham Karira, commented: “GlobalData expects the UK’s GDP to decline in 2020 due to severe […]
Read more
1 10 11 12 13 14 15